GB201601138D0 - New use - Google Patents

New use

Info

Publication number
GB201601138D0
GB201601138D0 GBGB1601138.9A GB201601138A GB201601138D0 GB 201601138 D0 GB201601138 D0 GB 201601138D0 GB 201601138 A GB201601138 A GB 201601138A GB 201601138 D0 GB201601138 D0 GB 201601138D0
Authority
GB
United Kingdom
Prior art keywords
new use
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1601138.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RSPR PHARMA AB
Original Assignee
RSPR PHARMA AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RSPR PHARMA AB filed Critical RSPR PHARMA AB
Priority to GBGB1601138.9A priority Critical patent/GB201601138D0/en
Publication of GB201601138D0 publication Critical patent/GB201601138D0/en
Priority to PCT/GB2017/050123 priority patent/WO2017125739A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB1601138.9A 2016-01-21 2016-01-21 New use Ceased GB201601138D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1601138.9A GB201601138D0 (en) 2016-01-21 2016-01-21 New use
PCT/GB2017/050123 WO2017125739A1 (en) 2016-01-21 2017-01-19 New use of pemirolast

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1601138.9A GB201601138D0 (en) 2016-01-21 2016-01-21 New use

Publications (1)

Publication Number Publication Date
GB201601138D0 true GB201601138D0 (en) 2016-03-09

Family

ID=55534727

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1601138.9A Ceased GB201601138D0 (en) 2016-01-21 2016-01-21 New use

Country Status (2)

Country Link
GB (1) GB201601138D0 (en)
WO (1) WO2017125739A1 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4122274A (en) * 1977-05-25 1978-10-24 Bristol-Myers Company 3-Tetrazolo-5,6,7,8-substituted-pyrido[1,2-a]pyrimidin-4-ones
WO2009007675A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and a p2 gamma 12 antagonist
US20160243122A1 (en) * 2014-10-23 2016-08-25 Rspr Pharma Ab Use of pemirolast in the treatment of acute asthma
CN105106147A (en) * 2015-09-07 2015-12-02 江苏飞马药业有限公司 Pemirolast potassium tablet and production technology thereof

Also Published As

Publication number Publication date
WO2017125739A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
AU201616678S (en) Cylindres
GB201502152D0 (en) Novel use
GB201509326D0 (en) Novel use
GB2546834B (en) Jet-effect use
GB201818605D0 (en) Nivel use
GB201403944D0 (en) New use
GB201416727D0 (en) Use
GB201522311D0 (en) Use
GB201522309D0 (en) Use
GB201416716D0 (en) Use
GB201613185D0 (en) Novel use
GB201521085D0 (en) Use
PL3469691T3 (en) Halbach-array configuration
GB201518466D0 (en) Use
GB201510077D0 (en) Use
GB201420095D0 (en) New use
GB201621447D0 (en) Use
GB201707846D0 (en) Use
GB201620095D0 (en) Novel use
GB201614590D0 (en) Novel use
GB201518831D0 (en) New use
GB201718676D0 (en) New use
GB201620350D0 (en) Use
GB201616240D0 (en) Use
GB201616203D0 (en) Use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)